<DOC>
	<DOC>NCT02838342</DOC>
	<brief_summary>This study will evaluate the potential immunomodulatory synergy of the association of metronomic cyclophosphamide (CMC) and interferon-alpha (IFN-alpha).</brief_summary>
	<brief_title>Pharmaco-immunological Study of Interferon-alpha and Metronomic Cyclophosphamide Association in Neuroendocrine Tumors</brief_title>
	<detailed_description />
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>performance status ECOGWHO â‰¤ 1 histologically proved neuroendocrine tumor with Ki67 &lt; or = 10%, metastatic or locally advanced without surgery possibility at least one measurable lesion based on RECIST criteria version 1.1 signed written informed consent previous treatment with interferon or cyclophosphamide treatment by immunosuppressive drugs diabetes complicated by coronary artery disease or vasculopathy severe respiratory failure, chronic respiratory failure, COPD history of severe heart failure severe renal or hepatic impairment diabetes complicated with coronary artery disease or vasculopathy alcoholism unweaned uncontrolled epilepsy and/or achievement of the central nervous system functions history of severe depressive syndrome presence or history of severe psychiatric condition, particularly severe depression, suicidal thoughts or attempted suicide decompensated liver cirrhosis severe myelosuppression psoriasis and sarcoidosis active disease condition or uncontrolled infection association with the yellow fever vaccine association with phenytoin in prophylaxis hypersensitivity against interferon or cyclophosphamide prior history of other malignancy except for: basal cell carcinoma of the skin, cervical intraepithelial neoplasia and other cancer curatively treated with no evidence of disease for at least 3 years pregnancy, breastfeeding or absence of adequate contraception for fertile patients patients under guardianship, curatorship or under the protection of justice</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>